An in-vivo pilot study into the effects of FDG-mNP in cancer in mice - Fig 2
- Omer Aras (2064373)
- Gillian Pearce (5646209)
- Adam J. Watkins (191684)
- Fuad Nurili (5126009)
- Emin Ilker Medine (5646212)
- Ozge Kozgus Guldu (595883)
- Volkan Tekin (5646215)
- Julian Wong (220552)
- Xianghong Ma (598393)
- Richard Ting (728474)
- Perihan Unak (595888)
- Oguz Akin (4261882)
Publication date
August 2018
DOI Publisher
Public Library of Science (PLoS)Abstract
Growth profiles of mice injected at 3 weeks of age with 8mk/kg ICG-conjugated FDG-mNPs (A). Representative fluorescent images of kidney (B, D) and brain (C, E) tissue sections from 3 and 6 month old mice injected with ICG-conjugated FDG-mNPs. Tissue intensity (arbitrary units) staining for ICG-conjugated FDG-mNPs normalised to nuclear Hoechst signal in 3 and 6 month old mice (F). n = 1 mouse per treatment group. Images in B-E are at 10x magnification. FDG: fluorodeoxyglucose; ICG: indocyanine; mNP: magnetic nanoparticle.</p
Add to ORKG